title: Duration of Antibiotic Therapy for Community-Acquired Pneumonia in the Era of Personalized Medicine.
authors.affiliation: Division of General Internal Medicine, Department of Medicine, University of California, San Francisco.
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Lee
authors.affiliation: Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Giesler
authors.affiliation: Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania3Veterans Affairs Pittsburgh Healthcare System, Center for Health Equity Research and Promotion, Pittsburgh, Pennsylvania.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Fine
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy*; D006801:Humans; D011014:Pneumonia / Q000188:drug therapy; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D057285:Precision Medicine
chemical_list: D000900:Anti-Bacterial Agents